Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin vs Gastric Lavage for Upper GI Bleeding Endoscopy
NCT01716572Phase 3Unknown
- Sponsor
- Bellvitge University Hospital
- Start
- Feb 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of erythromycin in Gastrointestinal Bleeding (GIB), sponsored by Bellvitge University Hospital. Primary endpoint: Visual quality of endoscopy at 30 days. Status: unknown.
02
Drugs
erythromycin
03
Conditions
Gastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT01716572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716572.